A Case Report of Influence of Free Tyrosine Kinase/Placental Growth Factor (SFLT-1/PLGF) Ratio Test for Preeclampsia on Clinical Decision Making in Screening Positive Women

1. Murphy DJ, Striate GM. Mortality and morbidity associated with early-onset preeclampsia. Hypertens Pregnancy. 2000;19(2):221-31.10.1081/PRG-10010013810877990Search in Google Scholar

2. Noris M, Perico N, Remuzzi G. Mechanisms of disease: preeclampsia. Nat Clin Practe. 2005;1(2):98-114.10.1038/ncpneph003516932375Search in Google Scholar

3. Shennan AH, Redman C, Cooper C, Milne F. Are most maternal deaths from preeclampsia avoidable? Lancet 2012;379:1686-7.10.1016/S0140-6736(11)60785-XSearch in Google Scholar

4. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592-94.10.1126/science.111172615947178Search in Google Scholar

5. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: The role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123(24):2856-69.10.1161/CIRCULATIONAHA.109.853127314878121690502Search in Google Scholar

6. Liu A, Wen SW, Bottomley J, Walker MC, Smith G. Utilization of health care services of pregnant women complicated by preeclampsia in Ontario. Hypertens Pregnancy. 2009;28(1):76-84.10.1080/1064195080236625219165672Search in Google Scholar

7. Delahaije DH, Smits LJ, van Kuijk SM, Peeters LL, Duvekot JJ, Ganzevoort W, et al. Care-as- usual provided to formerly preeclamptic women in the Netherlands in the next pregnancy: health care consumption, costs and maternal and child outcome. Eur J Obstet Gynecol Reprod Biol 2014;179:240-5.10.1016/j.ejogrb.2014.04.03324835859Search in Google Scholar

8. Rath W, Fischer Th. The Diagnosis and Treatment of Hypertensive Disorders of Pregnancy. New Findings for Antenatal and Inpatient Care. Dtsch Arztebl Int 2009;106(45): 733-8.10.3238/arztebl.2009.0733Search in Google Scholar

9. Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J ObstetGynecol2010;202(2):161.e1–161.e11.10.1016/j.ajog.2009.09.01619850276Search in Google Scholar

10. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Zeisler H, Calda P, et al. New gestational phase specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension 2014;63(2):346-52.10.1161/HYPERTENSIONAHA.113.0178724166751Search in Google Scholar

11. Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstr M, et al. Predictive value of the sFlt-1: PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374(1):13-22.10.1056/NEJMoa141483826735990Search in Google Scholar